QUOTED. June 22, 2018. Amanda Micklus.
Executive Summary
Roche bought out Foundation Medicine in full. Check out what Datamonitor Health analyst Amanda Micklus says about how the deal fits with Roche's current M&A strategy.
"The Foundation deal seems a natural next step for Roche. It seems to be taking more of an open innovation approach, whereby [Foundation and Flatiron] are continuing to partner with others, even some of Roche’s peers, to advance research projects." – Amanda Micklus, principal analyst, Datamonitor Healthcare
- Find out more: Roche Pushes Personalization With $2.4Bn Foundation Buy-Out
Click here for a free trial of Medtech Insight